Company Overview
EDGC provides the value for healthy lifestyle by suggesting customized healthcare based on genome information.
EDGC is the international joint venture established in 2013 between EONE Laboratories and Diagnomics. Through genome analysis, EDGC has provided genetic screening tests to help people predict cancer and diseases and to offer personalized healthcare.
EDGC has developed cutting-edge technology for genome analysis through constant research and development and has established a business network to expand its influence to the global market.